Cyclacel pharmaceuticals reports third quarter financial results and provides business update

Berkeley heights, n.j., nov. 12, 2024 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update.
CYCC Ratings Summary
CYCC Quant Ranking